CN1957963A - Compound Chinese traditional medicine for treating coronary heart disease, and andina pectoris - Google Patents
Compound Chinese traditional medicine for treating coronary heart disease, and andina pectoris Download PDFInfo
- Publication number
- CN1957963A CN1957963A CN 200510017256 CN200510017256A CN1957963A CN 1957963 A CN1957963 A CN 1957963A CN 200510017256 CN200510017256 CN 200510017256 CN 200510017256 A CN200510017256 A CN 200510017256A CN 1957963 A CN1957963 A CN 1957963A
- Authority
- CN
- China
- Prior art keywords
- heart disease
- chinese medicine
- coronary heart
- medicine compound
- pectoris
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A Chinese medicine in the form of pill, tablet, infusion, oral liquid, or capsule for treating coronary heart disease and angina pectoris is prepared from 13 Chinese-medicinal materials including saffron, safflower, Chuan-xiong rhizome, red sage root, etc.
Description
Technical field
The present invention relates to a kind of treatment coronary heart disease, anginal Chinese medicine compound.
Background technology
Coronary heart disease, it is the abbreviation of coronary atherosclerotic heart disease, be a kind of because coronary artery stationarity (atherosclerosis) or dynamic property (vasospasm) stenosis or occlusion, the coronary circulation obstacle takes place, cause that myocardial oxygen is unbalance and cause myocardial ischemia-anoxemia or downright bad a kind of heart disease between needing, also claim ischemic heart desease.Coronary heart disease is commonly encountered diseases, the frequently-occurring disease of middle-aged and elderly people, accounts for more than 20% of deaths from heart disease rate in China.
The cause of disease of coronary heart disease is atherosclerosis or vasospasm, vasospasm is uncommon, atherosclerosis is more common, but can't find out at present and cause atherosclerotic basic reason, Chinese and western medicine is consistent to be thought, atherosclerosis and psychentonia, overworked, hypertension, hyperlipidemia, hyperglycemia, smoking, drink, fat, hypomotility is relevant.
Angina pectoris is a kind ofly to be caused by the temporary transient ischemia of cardiac muscle, anoxia, mainly shows as ictal chest pain or chest discomfort, tired, excited, be satiated with food, catch cold, rainy weather, acute circulatory failure etc. all can bring out angina pectoris.Angina pectoris also is one of common disease of serious harm human health.
At present, the Therapeutic Method of coronary heart disease is a lot, and internal medicine adopts Drug therapy more, but because ill degree difference, patient's body situation difference are big, has caused very big difficulty for the compatibility and the selection of medicine
Development along with the conduit interventional therapy method, pass through coronarography, can accurately diagnose narrow and closed position, be convenient to select suitable therapeutic method, as percutaneous coronary artery angiography intracavity forming operation (PTCA) intracoronary stening etc., these methods can be recovered cardiac function faster, but along with long-term clinical practice is found, this method also is not suitable for all patients, and some patient's postoperative occurs narrow once more or far-end blocks, and should not put up a bridge.
It is better that laser blood fortune is built the art effect, but the misery that the patient is subjected to is big, still has phenomenon repeatedly, and has the patient of complication can't carry out this kind therapy.
Summary of the invention
The invention provides a kind of Chinese medicine compound, can effectively treat coronary heart disease, angina pectoris, therapeutic effect can manifest at short notice, and side effect is little, and is strong to the adaptability of patient colony.
The present invention treats coronary heart disease, anginal technical scheme is:
Modern pharmacological research proves: the free cinnamic acid that contains in the Styrax, and cinnamic acid fat can be used for treating coronary heart disease and angina pectoris; Stigma Croci contains the composition of multiple glycoside, can obviously increase blood flow coronarius, effectively strengthens the blood supply of cardiac muscle oxygen supply; Flos Carthami can prevent arteriosclerosis, and treatment angina pectoris, heart failure, hypertension: Rhizoma Chuanxiong, Radix Salviae Miltiorrhizae, Radix Notoginseng have dissipating blood stasis, hemostasis, pain-relieving functions, can effectively alleviate breast ventral spine pain; Cinnabaris then can clearing away heart-fire for tranquillization, have function of detoxification; Borneolum Syntheticum can have one's ideas straightened out refreshment, clearing away heat to alleviate pain; But the Radix Astragali, Fructus Schisandrae Chinensis invigorating QI to consolidate the body surface resistance.
Form principal agent for 7～30 parts with 7～30 parts of Stigma Crocis, 1～4 part of Styrax, Flos Carthami, add accessory drugss such as 7.5～30 parts of Rhizoma Chuanxiongs, 15～60 parts of Radix Salviae Miltiorrhizaes, 10～40 parts of Radix Notoginseng, mix compositions such as an amount of Cinnabaris, Borneolum Syntheticum, the Radix Astragali, Fructus Schisandrae Chinensis, Semen Ziziphi Spinosae, Mentholum, XIAOZAO, Semen Armeniacae Amarum again, compatibility becomes compound recipe, can be prepared into forms such as the pill that can be accepted by human body, tablet, electuary, oral liquid, capsule.
Use the beneficial effect of this compound recipe to be: the Chinese medicine that utilizes multiple known composition, again compatibility is formed compound recipe, be prepared into forms such as the pill that can be accepted by human body, tablet, electuary, oral liquid, capsule, can effectively treat coronary heart disease, angina pectoris, therapeutic effect can manifest at short notice, and is stronger to the adaptability of patient colony.
The specific embodiment
It is illustration only that the compound recipe that relates in the specific embodiment is formed, and does not use as claim.
(1) Rhizoma Chuanxiong 15g Radix Salviae Miltiorrhizae 30g Styrax 2g Borneolum Syntheticum 2g Fructus Schisandrae Chinensis 20g Flos Carthami 15g is ground into fine powder, sieves; Radix Astragali 50g Stigma Croci 15g Radix Notoginseng 20g extracting in water three times, filtrate concentrates, and adds above-mentioned fine powder mixing, makes pill, and external Cinnabaris 3g hangs clothing, called after coronary disease rehabilitation ball.Below be the clinical treatment example: patient Lee *, 57 years old, suffered from coronary heart disease 15 years, and took multiple medicine, effect is undesirable, can only keep with several Western medicine now, take a course of treatment of this coronary disease rehabilitation ball (30 days) the back patient's condition and be clearly better, cure substantially after taking 3 courses of treatment continuously, till now (in JIUYUE, 2005) in 2 years only because overworked morbidity once, but symptom is slight, very fast recovery.
(2) Radix Astragali 20g Radix Salviae Miltiorrhizae 25g Radix Notoginseng 20g Fructus Schisandrae Chinensis 20g Rhizoma Chuanxiong 15g Flos Carthami 15g Borneolum Syntheticum 3g Cinnabaris 2g Stigma Croci 20g Styrax 2g Mentholum 3g XIAOZAO 15g Semen Armeniacae Amarum 15g is formed compound recipe, the treatment angina pectoris.Below for clinical example: the patient opens * *, 55 years old, suffer from angina pectoris for many years, use multiple effect of drugs not obvious, take this compound tablet after 2 months symptom obviously alleviate, originally 3-5 days the morbidity once, only in period in a medicine morbidity twice, pain relief during morbidity is taken medicine and is not had the morbidity phenomenon after two months.
Claims (4)
1, a kind of treatment coronary heart disease, anginal Chinese medicine compound is characterized in that: this Chinese medicine compound mainly is made up of Styrax 1-4 part, Stigma Croci 7.5-30 part, Flos Carthami 7.5-30 part.
2, treatment coronary heart disease according to claim 1, anginal Chinese medicine compound is characterized in that: also comprise Rhizoma Chuanxiong 7.5-30 part, Radix Salviae Miltiorrhizae 15-60 part, Radix Notoginseng 10-40 part in this Chinese medicine compound.
3, treatment coronary heart disease according to claim 1, anginal Chinese medicine compound is characterized in that: also comprise compositions such as Cinnabaris, Borneolum Syntheticum, Mentholum, the Radix Astragali, Fructus Schisandrae Chinensis, Semen Ziziphi Spinosae, XIAOZAO in this Chinese medicine compound.
4, according to the described treatment coronary heart disease of claim 1-3, anginal Chinese medicine compound, it is characterized in that: this Chinese medicine compound has been made coronary disease rehabilitation ball, can also make the form that human bodies such as tablet, electuary, oral liquid, capsule can be accepted as required simultaneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017256 CN1957963A (en) | 2005-11-02 | 2005-11-02 | Compound Chinese traditional medicine for treating coronary heart disease, and andina pectoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510017256 CN1957963A (en) | 2005-11-02 | 2005-11-02 | Compound Chinese traditional medicine for treating coronary heart disease, and andina pectoris |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1957963A true CN1957963A (en) | 2007-05-09 |
Family
ID=38069916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510017256 Pending CN1957963A (en) | 2005-11-02 | 2005-11-02 | Compound Chinese traditional medicine for treating coronary heart disease, and andina pectoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1957963A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922647A (en) * | 2015-07-14 | 2015-09-23 | 程子轩 | Traditional Chinese medicine health product for preventing and adjuvantly treating coronary heart disease and preparation method thereof |
| CN105902694A (en) * | 2016-04-25 | 2016-08-31 | 吕建波 | Medicine composition for assisting coronary heart disease postoperative recovery |
-
2005
- 2005-11-02 CN CN 200510017256 patent/CN1957963A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104922647A (en) * | 2015-07-14 | 2015-09-23 | 程子轩 | Traditional Chinese medicine health product for preventing and adjuvantly treating coronary heart disease and preparation method thereof |
| CN105902694A (en) * | 2016-04-25 | 2016-08-31 | 吕建波 | Medicine composition for assisting coronary heart disease postoperative recovery |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101011522B (en) | Chinese traditional medicine for treating cardiopathy | |
| CN102512632B (en) | Chinese herbal composition for treating abnormal menstruation | |
| CN104758852A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104758806A (en) | Decocted extract for treating coronary heart disease and preparation method thereof | |
| CN104258350A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome and preparation method of traditional Chinese medicine preparation | |
| CN101524470B (en) | Traditional Chinese medicine preparation for curing angiocardiopathy stent restenosis and preparation method thereof | |
| CN103041336A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
| CN103893670B (en) | Traditional Chinese medicine pill used for treating cardia-cerebrovascular diseases | |
| CN1957963A (en) | Compound Chinese traditional medicine for treating coronary heart disease, and andina pectoris | |
| CN102406743B (en) | Traditional Chinese preparation for treating cerebral thrombosis | |
| CN104940597A (en) | Chinese herbal composition used for treating myocardial infarction, and preparation method of Chinese herbal composition | |
| CN113041324A (en) | Traditional Chinese medicine composition for treating qi deficiency and blood stasis type diabetic nephropathy and preparation method thereof | |
| CN102631607B (en) | Medicament for treating cardiovascular diseases and preparation method thereof | |
| CN105232677A (en) | Traditional Chinese medicine composition for treating myocardial infarction and preparation method of traditional Chinese medicine composition | |
| CN101721518A (en) | Traditional Chinese medicine for treating senile constipation | |
| CN105126034A (en) | Pharmaceutical preparation for treating coronary heart disease | |
| CN1280835A (en) | Chinese-medicinal capsule for treating hyperlipomia | |
| CN104623544A (en) | Traditional Chinese medicine preparation capable of tonifying spleen and eliminating dampness for treating moderate fatty liver and preparation method of traditional Chinese medicine preparation | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN104398626A (en) | Rheumatic heart disease merging palpitation heart and spleen-supplementing medicament and preparation method thereof | |
| CN103610893A (en) | Traditional Chinese medicine for treating coronary disease | |
| CN105311425A (en) | Application of pharmaceutical composition containing folium artemisiae argyi in preparing medicine for treating myocardial infarction | |
| CN104644916A (en) | Traditional Chinese medicine composition for treating hypertension | |
| CN104306565A (en) | Traditional Chinese medicine preparation for treating qi stagnation and blood stasis type angina pectoris and preparation method thereof | |
| CN104225311A (en) | Neurasthenia heart and spleen tonifying medicament and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20070509 |